Fundz

Pro Mis Neurosciences Inc. reported raising $158,000 in an initial SEC Form D filing, from an offering of $217,000

PUBLIC · PMNAug 24, 2016

Amount Raised

$158,000

$158,000 sold, per SEC Form D (first sale Aug 24, 2016)

Round Type

Venture

TorontoBiotechnology

Who to call at ProMIS Neurosciences, and when

A new round usually means ProMIS Neurosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ProMIS Neurosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ProMIS Neurosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ProMIS Neurosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ProMIS Neurosciences

Location

1920 Yonge St., Suite 200

Toronto, Ontario, Canada

About

ProMIS Neurosciences is a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies selective for toxic oligomers associated with the development and progression of neurodegenerative and other misfolded protein diseases. The Company’s proprietary target discovery engine, EpiSelect™, predicts novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins that cause neurodegenerative and other misfolded protein diseases, including Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), multiple system atrophy (MSA), and Parkinson’s Disease (PD).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ProMIS Neurosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsEugene W., DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for ProMIS Neurosciences's next move

See what Strategic adds

ProMIS Neurosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.